Multinational pharmaceutical companies are facing strains on their revenues as many of their patents covering their biggest selling medicines are due to expire. But in China an SPC ruling on pen designs has shown that other IP rights could come to the rescue

The limit on the total of the holdings of the A shares of a single listed company by all QFIIs is now increased from 20% to 30% of the listed company's total shares. The qualification thresholds for QFIIs have also been relaxed.

New draft Regulations will allow companies listed in China to offer stock ownership plans that could increase staff retention, but without additional incentives employees may be reluctant to participate

Shanghai was the first city to release details of its pilot carbon trading market as part of a national policy to encourage a low carbon economy, but questions remain over how the NDRC will regulate the trading platforms

Vincent Mu of Martin Hu & Partners looks at recent trends in litigation and arbitration in China and offers advice for foreign businesses on relevant issues

Foreign-invested partnerships have been around for two years and are starting to become more attractive as investors seek alternative vehicles. The structure is easy to set up and offers unparalleled tax benefits, but investors should be cautious of their liabilities

The Employment Contract Law is under review and has generated much public debate over the use of labour dispatch workers, but are the amendments enough to alter China's labour market?

Chinese outbound investment has grown exponentially in the past two years, but as domestic companies become more ambitious, does Hong Kong still have a role to play?

New Provisions have created competition between brokers by allowing foreign institutional investors to use more than one securities dealer